At a glance
ClinicalIndex Comparison RecordN/ACompleted· 131 enrolled
Drug / intervention
Tachosilother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study
In Brief
An observational study evaluating Tachosil for Laparoscopy. Completed, enrolled 131 participants across 8 sites.
Detailed Summary
The purpose of this study is to describe ease of use and satisfaction with application of the pre-rolled TachoSil in laparoscopic procedures within approved therapeutic indication as per Summary of Product Characteristics (SmPC).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLaparoscopy
CountriesAustria
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 2016
Enrollment StartApr 2016
Primary CompletionAug 2017
TodayJul 2026
First PostedFeb 18, 2016
Enrollment StartApr 5, 2016
Primary CompletionAug 14, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.4 years ago
Interventions
Tachosilother
TachoSil is a collagen matrix that is coated with human fibrinogen and human thrombin.